Skip to main content
Top
Published in: International Urology and Nephrology 1/2011

01-03-2011 | Urology – Original Paper

Xanthogranulomatous pyelonephritis: critical analysis of 30 patients

Authors: Chin-Chi Kuo, Ching-Fang Wu, Chun-Chieh Huang, Yuan-Ju Lee, Wei-Chou Lin, Ching-Wei Tsai, Vin-Cent Wu, Yung-Ming Chen, Ming-Shiou Wu, Tzong-Shinn Chu, Kwan-Dun Wu

Published in: International Urology and Nephrology | Issue 1/2011

Login to get access

Abstract

Introduction and objective

Xanthogranulomatous pyelonephritis (XGP) is a chronic inflammatory condition of the kidneys. Nevertheless, disparities between the pre-operative and pathological diagnoses are frequently encountered. We reviewed all patients with XGP over a 17-year period to identify and characterize the pre-operative and pathological characteristics of the disease in our patients.

Methods

A comprehensive review of all nephrectomy patients with a pre-operative diagnosis of pyelonephritis at National Taiwan University Hospital from 1991 to 2008 with the pathological diagnosis of XGP was conducted to demonstrate the clinical and radiological characteristics of XGP.

Results

XGP was diagnosed in 30 (18.6%) of the 160 nephrectomies performed for pyelonephritis. Of the 30 patients with XGP, 25 were women (83.3%) and 20 (66.7%) were overweight (body mass index >23). Their mean age was 55.17 years. The average serum creatinine level was 1.68 mg/dL. The image findings included renal calculi (56.7%), staghorn stones (26.7%), and spread of the disease to the retroperitoneum and psoas muscle (33.3%). Escherichia coli (36.7%) was the most prevalent pathogen. The mortality of the two-stage surgical treatment was zero, and morbidity developed in only 1 patient (4.8%).

Conclusion

The key to accurate pre-operative diagnosis is to keep risk factors in mind such as age, sex, and renal calculi. Clinicians should maintain a high suspicion of XGP for early recognition and be aware of the care of chronic kidney disease. Finally, the association between XGP and central obesity warrants further research.
Literature
1.
go back to reference Schlagenhaufer F (1916) Uber eigentumlich staphylomykosen der neiven und des pararenalen bindegewebes. Frankfurt Z Pathol 19:139–148 Schlagenhaufer F (1916) Uber eigentumlich staphylomykosen der neiven und des pararenalen bindegewebes. Frankfurt Z Pathol 19:139–148
2.
go back to reference Ballesteros Sampol JJ (1989) Up-date on renal xanthogranulomatosis: (comparison of personal experience in 66 cases and the 720 cases from the literature). Actas Urol Esp 13:10–18PubMed Ballesteros Sampol JJ (1989) Up-date on renal xanthogranulomatosis: (comparison of personal experience in 66 cases and the 720 cases from the literature). Actas Urol Esp 13:10–18PubMed
3.
go back to reference Malek RS, Elder JS (1978) Xanthogranulomatous pyelonephritis: a critical analysis of 26 cases and of the literature. J Urol 119:589–593PubMed Malek RS, Elder JS (1978) Xanthogranulomatous pyelonephritis: a critical analysis of 26 cases and of the literature. J Urol 119:589–593PubMed
4.
go back to reference Rosi P, Selli C, Carini M, Rosi MF, Mottola A (1986) Xanthogranulomatous pyelonephritis: clinical experience with 62 cases. Eur Urol 12:96–100PubMed Rosi P, Selli C, Carini M, Rosi MF, Mottola A (1986) Xanthogranulomatous pyelonephritis: clinical experience with 62 cases. Eur Urol 12:96–100PubMed
5.
go back to reference Proca E, Lucan M, Alexianu M (1988) Xanthogranulomatous pyelonephritis. Comments apropos 145 clinical cases. Rev Chir Oncol Radiol ORL Oftalmol Stomatol Chir 37:451–466 Proca E, Lucan M, Alexianu M (1988) Xanthogranulomatous pyelonephritis. Comments apropos 145 clinical cases. Rev Chir Oncol Radiol ORL Oftalmol Stomatol Chir 37:451–466
6.
go back to reference Mhiri MN, Sellami F, Njeh M, Rebai T, Smida ML (1991) Xanthogranulomatous pyelonephritis. Apropos of 42 cases. Ann Urol 25:113–117 Mhiri MN, Sellami F, Njeh M, Rebai T, Smida ML (1991) Xanthogranulomatous pyelonephritis. Apropos of 42 cases. Ann Urol 25:113–117
7.
go back to reference Chuang CK, Lai MK, Chang PL et al (1992) Xanthogranulomatous pyelonephritis: experience in 36 cases. J Urol 147:333–336PubMed Chuang CK, Lai MK, Chang PL et al (1992) Xanthogranulomatous pyelonephritis: experience in 36 cases. J Urol 147:333–336PubMed
8.
go back to reference Fernandez Rodriguez A, Camarasa Garcia F, Guerra Prieto MF, Macian Cervera MJ, Beltran Beltran S, Puras Tellaeche A (1997) Xanthogranulomatous pyelonephritis: experience at the General Hospital of Albacete. Report of 16 cases. An Med Interna 14:62–66PubMed Fernandez Rodriguez A, Camarasa Garcia F, Guerra Prieto MF, Macian Cervera MJ, Beltran Beltran S, Puras Tellaeche A (1997) Xanthogranulomatous pyelonephritis: experience at the General Hospital of Albacete. Report of 16 cases. An Med Interna 14:62–66PubMed
9.
go back to reference Zorzos I, Moutzouris V, Korakianitis G, Katsou G (2003) Analysis of 39 cases of xanthogranulomatous pyelonephritis with emphasis on CT findings. Scand J Urol Nephrol 37:342–347PubMedCrossRef Zorzos I, Moutzouris V, Korakianitis G, Katsou G (2003) Analysis of 39 cases of xanthogranulomatous pyelonephritis with emphasis on CT findings. Scand J Urol Nephrol 37:342–347PubMedCrossRef
10.
go back to reference Korkes F, Favoretto RL, Broglio M, Silva CA, Castro MG, Perez MD (2008) Xanthogranulomatous pyelonephritis: clinical experience with 41 cases. Urology 71:178–180PubMedCrossRef Korkes F, Favoretto RL, Broglio M, Silva CA, Castro MG, Perez MD (2008) Xanthogranulomatous pyelonephritis: clinical experience with 41 cases. Urology 71:178–180PubMedCrossRef
11.
go back to reference Masoom S, Venkataraman G, Jensen J, Flanigan RC, Wojcik EM (2009) Renal FNA-based typing of renal masses remains a useful adjunctive modality: evaluation of 31 renal masses with correlative histology. Cytopathology 20(1):50–55PubMedCrossRef Masoom S, Venkataraman G, Jensen J, Flanigan RC, Wojcik EM (2009) Renal FNA-based typing of renal masses remains a useful adjunctive modality: evaluation of 31 renal masses with correlative histology. Cytopathology 20(1):50–55PubMedCrossRef
12.
go back to reference Raziel A, Steinberg R, Kornreich L et al (1997) Xanthogranulomatous pyelonephritis mimicking malignant disease: is preservation of the kidney possible? Pediatr Surg Int 12:535–537PubMedCrossRef Raziel A, Steinberg R, Kornreich L et al (1997) Xanthogranulomatous pyelonephritis mimicking malignant disease: is preservation of the kidney possible? Pediatr Surg Int 12:535–537PubMedCrossRef
13.
go back to reference Perez LM, Netto JM, Induhara R, Mroczek-Musulman E (1999) Xanthogranulomatous pyelonephritis in an infant with an obstructed upper pole renal moiety. Urology 54:744PubMedCrossRef Perez LM, Netto JM, Induhara R, Mroczek-Musulman E (1999) Xanthogranulomatous pyelonephritis in an infant with an obstructed upper pole renal moiety. Urology 54:744PubMedCrossRef
14.
go back to reference Rassweiler J, Fornara P, Weber M et al (1998) Laparoscopic nephrectomy: the experience of the laparoscopy working group of the German Urologic Association. J Urol 160:18–21PubMedCrossRef Rassweiler J, Fornara P, Weber M et al (1998) Laparoscopic nephrectomy: the experience of the laparoscopy working group of the German Urologic Association. J Urol 160:18–21PubMedCrossRef
15.
go back to reference Tobias-Machado M, Lasmar MT, Batista LT, Forseto PH Jr, Juliano RV, Wroclawski ER (2005) Laparoscopic nephrectomy in inflammatory renal disease: proposal for a staged approach. Int Braz J Urol 31:22–28PubMed Tobias-Machado M, Lasmar MT, Batista LT, Forseto PH Jr, Juliano RV, Wroclawski ER (2005) Laparoscopic nephrectomy in inflammatory renal disease: proposal for a staged approach. Int Braz J Urol 31:22–28PubMed
16.
go back to reference Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41PubMedCrossRef Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41PubMedCrossRef
17.
go back to reference Levey AS, Coresh J, Balk E et al (2003) National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139:137–147PubMed Levey AS, Coresh J, Balk E et al (2003) National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139:137–147PubMed
18.
go back to reference Ko GT, Tang J, Chan JC et al (2001) Lower BMI cut-off value to define obesity in Hong Kong Chinese: an analysis based on body fat assessment by bioelectrical impedance. Br J Nutr 85:239–242PubMedCrossRef Ko GT, Tang J, Chan JC et al (2001) Lower BMI cut-off value to define obesity in Hong Kong Chinese: an analysis based on body fat assessment by bioelectrical impedance. Br J Nutr 85:239–242PubMedCrossRef
19.
go back to reference Saavedra Jo S, Pow-Sang Godoy M, Benavente Corrales V et al (2004) Xanthogranulomatous pyelonephritis: clinical, radiological and pathologic characteristics. Arch Esp Urol 57:595–600PubMed Saavedra Jo S, Pow-Sang Godoy M, Benavente Corrales V et al (2004) Xanthogranulomatous pyelonephritis: clinical, radiological and pathologic characteristics. Arch Esp Urol 57:595–600PubMed
20.
go back to reference Al-Ghazo MA, Ghalayini IF, Matalka II, Al-Kaisi NS, Khader YS (2006) Xanthogranulomatous pyelonephritis: analysis of 18 cases. Asian J Surg 29:257–261PubMedCrossRef Al-Ghazo MA, Ghalayini IF, Matalka II, Al-Kaisi NS, Khader YS (2006) Xanthogranulomatous pyelonephritis: analysis of 18 cases. Asian J Surg 29:257–261PubMedCrossRef
21.
go back to reference Loffroy R, Guiu B, Watfa J, Michel F, Cercueil JP, Krause D (2007) Xanthogranulomatous pyelonephritis in adults: clinical and radiological findings in diffuse and focal forms. Clin Radiol 62:884–890PubMedCrossRef Loffroy R, Guiu B, Watfa J, Michel F, Cercueil JP, Krause D (2007) Xanthogranulomatous pyelonephritis in adults: clinical and radiological findings in diffuse and focal forms. Clin Radiol 62:884–890PubMedCrossRef
22.
go back to reference Matthews GJ, McLorie GA, Churchill BA, Steckler RE, Khoury AE (1995) Xanthogranulomatous pyelonephritis in pediatric patients. J Urol 153:1958–1959PubMedCrossRef Matthews GJ, McLorie GA, Churchill BA, Steckler RE, Khoury AE (1995) Xanthogranulomatous pyelonephritis in pediatric patients. J Urol 153:1958–1959PubMedCrossRef
23.
go back to reference Tsai C-W, Chan D-C, Kuo C-C, Lee Y-J, Huang C-C (2009) Kidney packed with fat, pus and stone-xanthogranulomatous pyelonephritis. NDT plus 2:257–258CrossRef Tsai C-W, Chan D-C, Kuo C-C, Lee Y-J, Huang C-C (2009) Kidney packed with fat, pus and stone-xanthogranulomatous pyelonephritis. NDT plus 2:257–258CrossRef
24.
go back to reference Dwivedi US, Goyal NK, Saxena V et al (2006) Xanthogranulomatous pyelonephritis: our experience with review of published reports. ANZ J Surg 76:1007–1009PubMedCrossRef Dwivedi US, Goyal NK, Saxena V et al (2006) Xanthogranulomatous pyelonephritis: our experience with review of published reports. ANZ J Surg 76:1007–1009PubMedCrossRef
25.
go back to reference Guzzo TJ, Bivalacqua TJ, Pierorazio PM, Varkarakis J, Schaeffer EM, Allaf ME (2009) Xanthogranulomatous pyelonephritis: presentation and management in the era of laparoscopy. BJU Int 104:1265–1268PubMedCrossRef Guzzo TJ, Bivalacqua TJ, Pierorazio PM, Varkarakis J, Schaeffer EM, Allaf ME (2009) Xanthogranulomatous pyelonephritis: presentation and management in the era of laparoscopy. BJU Int 104:1265–1268PubMedCrossRef
26.
go back to reference Leoni FA, Kinleiner P, Revol M, Zaya A, Odicio A (2009) Xanthogranulomatous pyelonephritis: review of 10 cases. Arch Esp Urol 62:259–271PubMedCrossRef Leoni FA, Kinleiner P, Revol M, Zaya A, Odicio A (2009) Xanthogranulomatous pyelonephritis: review of 10 cases. Arch Esp Urol 62:259–271PubMedCrossRef
27.
go back to reference Reese PP, Feldman HI, Asch DA, Thomasson A, Shults J, Bloom RD (2009) Short-term outcomes for obese live kidney donors and their recipients. Transplantation 88:662–671PubMedCrossRef Reese PP, Feldman HI, Asch DA, Thomasson A, Shults J, Bloom RD (2009) Short-term outcomes for obese live kidney donors and their recipients. Transplantation 88:662–671PubMedCrossRef
28.
29.
go back to reference Tiu CM, Chou YH, Chiou HJ et al (2001) Sonographic features of xanthogranulomatous pyelonephritis. J Clin Ultrasound 29:279–285PubMedCrossRef Tiu CM, Chou YH, Chiou HJ et al (2001) Sonographic features of xanthogranulomatous pyelonephritis. J Clin Ultrasound 29:279–285PubMedCrossRef
30.
go back to reference Kim J (2004) Ultrasonographic features of focal xanthogranulomatous pyelonephritis. J Ultrasound Med 23:409–416PubMed Kim J (2004) Ultrasonographic features of focal xanthogranulomatous pyelonephritis. J Ultrasound Med 23:409–416PubMed
31.
go back to reference Fallatah A, Tarakji M, Amuesi J (2001) Xanthogranulomatous pyelonephritis: a retrospective study of 10 cases and review of the literature. Saudi J Kidney Dis Transpl 12:520–524PubMed Fallatah A, Tarakji M, Amuesi J (2001) Xanthogranulomatous pyelonephritis: a retrospective study of 10 cases and review of the literature. Saudi J Kidney Dis Transpl 12:520–524PubMed
32.
go back to reference Lumeng CN, Bodzin JL, Saltiel AR (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117:175–184PubMedCrossRef Lumeng CN, Bodzin JL, Saltiel AR (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117:175–184PubMedCrossRef
33.
go back to reference Swirski FK, Libby P, Aikawa E et al (2007) Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest 117:195–205PubMedCrossRef Swirski FK, Libby P, Aikawa E et al (2007) Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest 117:195–205PubMedCrossRef
34.
go back to reference Tacke F, Alvarez D, Kaplan TJ et al (2007) Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 117:185–194PubMedCrossRef Tacke F, Alvarez D, Kaplan TJ et al (2007) Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 117:185–194PubMedCrossRef
36.
37.
go back to reference Lear SA, Humphries KH, Kohli S, Chockalingam A, Frohlich JJ, Birmingham CL (2007) Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT). Am J Clin Nutr 86:353–359PubMed Lear SA, Humphries KH, Kohli S, Chockalingam A, Frohlich JJ, Birmingham CL (2007) Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT). Am J Clin Nutr 86:353–359PubMed
Metadata
Title
Xanthogranulomatous pyelonephritis: critical analysis of 30 patients
Authors
Chin-Chi Kuo
Ching-Fang Wu
Chun-Chieh Huang
Yuan-Ju Lee
Wei-Chou Lin
Ching-Wei Tsai
Vin-Cent Wu
Yung-Ming Chen
Ming-Shiou Wu
Tzong-Shinn Chu
Kwan-Dun Wu
Publication date
01-03-2011
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 1/2011
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-010-9778-8

Other articles of this Issue 1/2011

International Urology and Nephrology 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine